Canada Markets closed

Science 37 Holdings, Inc. (SNCE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6100-0.0100 (-0.62%)
At close: 04:00PM EDT
1.6100 0.00 (0.00%)
After hours: 05:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.6200
Open1.6000
Bid1.4900 x 800
Ask2.0900 x 900
Day's Range1.6000 - 1.7900
52 Week Range1.4300 - 15.1030
Volume252,497
Avg. Volume373,360
Market Cap184.678M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-8.8090
Earnings DateNov 14, 2022 - Nov 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.25
  • GlobeNewswire

    Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer

    Shipton joins Science 37 to help capitalize on the high demand for decentralized clinical trials and drive further growth into enterprise opportunitiesRESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced that Michael Shipton has been appointed Chief Commercial Officer to lead business development, strategic solutions, sales operations, and strategic pricing, effective today. With mor

  • GlobeNewswire

    Science 37 to Present at the Baird 2022 Global Healthcare Conference

    RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Baird Global Healthcare Conference in New York. Science 37’s management is scheduled to present on Tuesday, September 13, 2022, at 3:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the compan

  • GlobeNewswire

    Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

    By following the patient, home-based data collection enables more clinical trials to adopt agile (hybrid) and fully decentralized approaches.RESEARCH TRIANGLE PARK, N.C. and BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a partnership with leading digital health company, NuvoAir, to incorporate remote collection of respiratory endpoints data into clinical trial designs—helping to bypass the need for